Fully intermittent dosing with drugs for tuberculosis.

Author: MwandumbaH C, SquireS B

Paper Details 
Original Abstract of the Article :
BACKGROUND: The number of people infected with tuberculosis continues to rise world-wide. Rifampicin-containing treatment regimens can achieve high cure rates. Intermittent drug treatment delivered in the community has the potential to improve adherence to treatment. OBJECTIVES: The objective of th...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1002/14651858.CD000970

データ提供:米国国立医学図書館(NLM)

The Quest for Effective Intermittent Dosing in Tuberculosis Treatment

The battle against tuberculosis is like a continuous trek across a harsh desert landscape. This study focuses on finding more effective ways to deliver treatment for tuberculosis, like finding a more efficient way to navigate the desert. The researchers are investigating whether intermittent dosing, where medication is given less frequently, can be as effective as daily dosing. They are searching for a way to streamline treatment, making it easier for patients to adhere to the regimen, like finding a shorter route through the desert.

Intermittent Dosing: A Potential Shortcut Through the Desert?

The study found that intermittent dosing with rifampicin-containing regimens might be as effective as daily dosing in treating pulmonary tuberculosis. However, the study emphasized the need for more research to confirm this finding. It's like trying to find a shortcut through the desert before venturing out on a long journey.

Improving Patient Adherence: A Vital Step in Combating Tuberculosis

This research underscores the importance of improving patient adherence to treatment for tuberculosis. It's like ensuring a traveler has enough supplies and water to survive the long journey through the desert. The study suggests that intermittent dosing could be a helpful tool in this effort.

Dr.Camel's Conclusion

This study is a testament to the ongoing search for better ways to treat tuberculosis. It's like a camel's journey across the desert, where every step brings us closer to a more effective and efficient treatment strategy.

Date :
  1. Date Completed 2000-07-06
  2. Date Revised 2018-12-21
Further Info :

Pubmed ID

10796561

DOI: Digital Object Identifier

10.1002/14651858.CD000970

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.